SIRPA and neoplasm: As demonstrated in the tumor model, the binding between the transmembrane protein CD47 and the signal regulatory protein alpha (SIRPα) prevents phagocytosis of EVs by macrophages, thus increasing their blood concentration and improving their delivery to target sites [105,106].